Literature DB >> 4745860

Brief communication: In vivo protection against murine plasma cell tumor growth by in vitro activated syngeneic lymphocytes.

M Röllinghoff, H Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4745860     DOI： 10.1093/jnci/51.4.1317

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor.

Authors:  T J Eberlein; M Rosenstein; P Spiess; R Wesley; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

Review 2.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

3.  Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract.

Authors:  N Kan; K Ohgaki; T Inamoto; H Kodama
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.

Authors:  E Fernandez-Cruz; B A Woda; J D Feldman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.